Insights

Loading spinner
Gathering insights about Allogene Therapeutics

Allogene Therapeutics Tech Stack

Allogene Therapeutics uses 8 technology products and services including LinkedIn Ads, Databricks, imagesLoaded, and more. Explore Allogene Therapeutics's tech stack below.

  • LinkedIn Ads
    Advertising
  • Databricks
    Big Data Processing
  • imagesLoaded
    Javascript Libraries
  • SAP Master Data Governance
    Product Information Management
  • Hadoop
    Programming Languages
  • Microsoft Project
    Project Management
  • Google Analytics
    Web Analytics
  • HTML5
    Web Tools And Plugins

Media & News

Allogene Therapeutics's Email Address Formats

Allogene Therapeutics uses at least 1 format(s):
Allogene Therapeutics Email FormatsExamplePercentage
First.Last@allogene.comJohn.Doe@allogene.com
94%
Last@allogene.comDoe@allogene.com
4%
Fir.Last@allogene.comJoh.Doe@allogene.com
1%
First@allogene.comJohn@allogene.com
1%

Frequently Asked Questions

Where is Allogene Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Allogene Therapeutics's main headquarters is located at 210 East Grand Avenue South San Francisco, California 94080 United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Allogene Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Allogene Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Allogene Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Allogene Therapeutics is a publicly traded company; the company's stock symbol is ALLO.

What is Allogene Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Allogene Therapeutics's official website is allogene.com and has social profiles on LinkedInCrunchbase.

What is Allogene Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Allogene Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Allogene Therapeutics have currently?

Minus sign iconPlus sign icon
As of May 2026, Allogene Therapeutics has approximately 208 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Scientific Officer: B. S.Vice President Research& Development: A. A.Vice President And Head Of Clinical Operations: A. L.. Explore Allogene Therapeutics's employee directory with LeadIQ.

What industry does Allogene Therapeutics belong to?

Minus sign iconPlus sign icon
Allogene Therapeutics operates in the Biotechnology Research industry.

What technology does Allogene Therapeutics use?

Minus sign iconPlus sign icon
Allogene Therapeutics's tech stack includes LinkedIn AdsDatabricksimagesLoadedSAP Master Data GovernanceHadoopMicrosoft ProjectGoogle AnalyticsHTML5.

What is Allogene Therapeutics's email format?

Minus sign iconPlus sign icon
Allogene Therapeutics's email format typically follows the pattern of First.Last@allogene.com. Find more Allogene Therapeutics email formats with LeadIQ.

How much funding has Allogene Therapeutics raised to date?

Minus sign iconPlus sign icon
As of May 2026, Allogene Therapeutics has raised $110M in funding. The last funding round occurred on May 13, 2024 for $110M.

When was Allogene Therapeutics founded?

Minus sign iconPlus sign icon
Allogene Therapeutics was founded in 2017.

Allogene Therapeutics

Biotechnology ResearchCalifornia, United States201-500 Employees

Allogene Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, focused on developing allogeneic chimeric antigen receptor T cell products for cancer and autoimmune diseases. The firm aims to deliver readily available cell therapy on demand, with improved reliability and greater scale to reach more patients.

It operates within the biotechnology research sector, pursuing an off-the-shelf approach to CAR T therapies. In 2026, the company expanded the pivotal ALPHA3 Phase 2 trial to South Korea and Australia.

Section iconCompany Overview

Headquarters
210 East Grand Avenue South San Francisco, California 94080 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ALLO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
201-500

Section iconFunding & Financials

  • $110M

    Allogene Therapeutics has raised a total of $110M of funding over 4 rounds. Their latest funding round was raised on May 13, 2024 in the amount of $110M.

  • $1M

    Allogene Therapeutics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $110M

    Allogene Therapeutics has raised a total of $110M of funding over 4 rounds. Their latest funding round was raised on May 13, 2024 in the amount of $110M.

  • $1M

    Allogene Therapeutics's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.